Pseudomonas infection signals poor outcome for COPD patients
May 30, 2012 - Patients with chronic obstructive pulmonary disease who are infected with Pseudomonas aeruginosa have a worse clinical outcome and are more likely to be hospitalized than those without the infection, states recent research. (Source: MedWire News - Respiratory)
CHMP backs Bretaris Genuair for COPD
May 30, 2012 - The Committee issued a positive opinion of Bretaris Genuair as maintenance bronchodilator for COPD (Source: Pharmacy Europe)
Emphysema Patients' Lung Function Improved With Metal Wire Implanted
May 28, 2012 - Results of a multi-center international trial have shown that a tiny, resilient metal wire called a lung volume reduction coil (LVRC), designed to gather and compress diseased lung tissue, may offer relief to patients with severe heterogeneous emphysema, a subtype of the disease that involves specific, usually isolated areas of the lungs. The study was presented at the ATS 2012 International Conference in San Francisco, demonstrating that the wire can easily be implanted, and potentially replace more invasive procedures to improving lung function in these patients... (Source: Health News from Medical News Today)
T Lymphocyte Insensitivity to Corticosteroids in COPDT Lymphocyte Inse
May 28, 2012 - Do lymphocytes play a role in corticosteroid insensitivity? Respiratory Research (Source: Medscape Today Headlines)
European CHMP adopts positive opinion on aclidinium bromide (Eklira Ge
May 27, 2012 - Source: EMA Area: News The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the granting of a marketing authorisation for aclidinium bromide (Eklira Genuair 322 mcg, inhalation powder), a long-acting, inhaled anticholinergic agent intended for the bronchodilator treatment of patients with chronic obstructive pulmonary disease (COPD). (Source: NeLM - News)
NU-COPD (Guaifenesin And Phenylephrine Hydrochloride) Tablet [CARWIN A
May 22, 2012 - Updated Date: May 23, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
P. aeruginosa bacteria associated with increased hospitalizations in C
May 22, 2012 - (American Thoracic Society) Patients with chronic obstructive pulmonary disease (COPD) who become infected with the bacterium Pseudomonas aerguinosa are more likely to have worse clinical outcomes and experience more hospitalizations during the course of their disease than COPD patients who are not infected, according to researchers from Buffalo, N.Y. (Source: EurekAlert! - Infectious and Emerging Diseases)
Results of Phase II Study of Boehringer Ingelheim?s Investigational Br
May 22, 2012 - Data presented at the 2012 Annual International Conference of the American Thoracic Society (ATS 2012) San Francisco, CA, May 21, 2012 – Data from a Phase II trial of olodaterol presented today at the 2012 Annual International Conference... (Source: Drugs.com - Clinical Trials)
Bone screening recommended for COPD veterans
May 22, 2012 - Male veterans with chronic obstructive pulmonary disease should be screened for osteoporosis, say US researchers who found a high untreated prevalence of the disease in this population. (Source: MedWire News - Bone Health)
Patients With COPD Likely To Suffer Comorbidities
May 22, 2012 - The majority of patients with chronic obstructive pulmonary disease (COPD) referred for pulmonary rehabilitation have multiple extra-pulmonary comorbidities, according to a new study from the Netherlands. "Comorbidities were common in our sample of 213 COPD patients from the CIRO Comorbidity (CIROCO) study, and most patients had varying combinations of comorbidities," said Lowie Vanfleteren, MD, of CIRO+, a center of expertise in chronic organ failure in Horn, the Netherlands, which is connected to the Maastricht University Medical Center... (Source: Health News from Medical News Today)




Connect on Facebook
Follow us on Twitter
Subscribe